Circular Genomics

Raises and deals from press releases

• Raise Series A · $15M · announced Dec 1, 2025 Company release ↗
  Source quote

  • Dec 1, 2025 · Company release ↗
    “SAN DIEGO, Dec. 1, 2025 -- Circular Genomics, Inc., the world-leading developer of circular RNA-based precision medicine tools for neurology and psychiatry, today announced the successful closure of a $15 million Series A financing round”
• Deal Lilly deal · amount not disclosed · announced Mar 17, 2025 Company release ↗
  Source quote

  • Mar 17, 2025 · Company release ↗
    “Circular Genomics' move to the Lilly Gateway Labs community will enhance scientific collaboration and innovation to foster the development of its Alzheimer's disease diagnostic and prognostic blood tests SAN DIEGO”
• Raise Series A · $8.3M · announced Jan 24, 2024 Company release ↗
  Source quote

  • Jan 24, 2024 · Company release ↗
    “Albuquerque, New Mexico, January 24, 2024 - Circular Genomics, the global leader in advancing circular RNA biomarkers for precision psychiatry and neurology, today announced the closing of an $8.3 Million Series A investment round”

Raises announced in these releases: $23.3M disclosed.

From the company’s own releases; this list is partial. All raises and deals